Masimo Corporation (LON:0JZ2)
London
· Delayed Price · Currency is GBP · Price in USD 168.98
+2.32 (1.39%)
At close: Jun 30, 2025
Masimo Revenue
Masimo had revenue of $372.00M USD in the quarter ending March 29, 2025, with 9.54% growth. This brings the company's revenue in the last twelve months to $2.13B, up 16.68% year-over-year. In the year 2024, Masimo had annual revenue of $2.09B with 2.26% growth.
Revenue (ttm)
$2.13B
Revenue Growth
+16.68%
P/S Ratio
4.15
Revenue / Employee
$590.78K
Employees
3,600
Market Cap
6.82B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 28, 2024 | 2.09B | 46.30M | 2.26% |
| Dec 30, 2023 | 2.05B | 12.30M | 0.60% |
| Dec 31, 2022 | 2.04B | 796.60M | 64.28% |
| Jan 1, 2022 | 1.24B | 95.50M | 8.35% |
| Jan 2, 2021 | 1.14B | 205.86M | 21.95% |
| Dec 28, 2019 | Pro | Pro | Pro |
| Dec 29, 2018 | Pro | Pro | Pro |
| Dec 30, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Jan 2, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 42.56B |
| GSK plc | 31.53B |
| Haleon | 11.23B |
| Smith & Nephew | 4.64B |
| ConvaTec Group | 1.83B |
| Hikma Pharmaceuticals | 2.50B |
| HUTCHMED (China) | 503.39M |
| Genus | 671.60M |
Masimo News
- 20 days ago - Here's How Much You Would Have Made Owning Masimo Stock In The Last 10 Years - Benzinga
- 22 days ago - MASI INVESTIGATION ALERT: Johnson Fistel PLLP Investigates the Directors and Officers of Masimo Corporation for Breach of Fiduciary Duties - GlobeNewsWire
- 22 days ago - New Study Finds Masimo SedLine® Brain Function Monitoring Offers Significant Advantages During Pediatric Anesthesia - Financial Post
- 22 days ago - New Study Finds Masimo SedLine® Brain Function Monitoring Offers Significant Advantages During Pediatric Anesthesia - Business Wire
- 4 weeks ago - MASI INVESTIGATION ALERT: Johnson Fistel PLLP Investigates the Directors and Officers of Masimo Corporation for Breach of Fiduciary Duties - Business Wire
- 4 weeks ago - Here's How Much $100 Invested In Masimo 15 Years Ago Would Be Worth Today - Benzinga
- 5 weeks ago - Masimo to reaffirm outlook; rules out impact from cybersecurity event - Seeking Alpha
- 5 weeks ago - Masimo to Present in the Jefferies Global Healthcare Conference - Business Wire